Enhancing Adverse Drug Reaction Reporting Among Community Pharmacists in Anambra State, Nigeria

A Pilot Multifaceted Strategy to Enhance Adverse Drug Reaction Reporting Among Community Pharmacists: A Cluster Randomized Controlled Trial in Anambra State, Nigeria

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202501788539541

Enrollment

Registered

2025-01-27

Start date

2025-02-03

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Drug Reporting

Interventions

Group 3

Group 1

Group 2

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Availability of a private consultation area Registration with PCN Regular availability of a pharmacist.

Exclusion criteria

Exclusion criteria: Pharmacies with only intern pharmacists Pharmacies with pharmacists that are not mentally stable at the time of the study

Design outcomes

Primary

Measure	Time frame
Adverse Drug Reporting Rate	—

Secondary

Measure	Time frame
Knowledge, attitudes, practices, and the quality of reports	—

Countries

Nigeria

Contacts

Public ContactNkechi Esomonu

Researcher at Nnamdi Azikiwe University

npm.esomonu@unizik.edu.ng+2348026422569

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026